Vericel (VCEL) Gross Margin Growth (3y) (2014 - 2026)

Vericel (VCEL) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 734.00

Historic Data

Download Data
DateValue
Mar 31, 2026 734.00
Dec 31, 2025 611.00
Sep 30, 2025 762.00
Jun 30, 2025 1,165.00
Mar 31, 2025 355.00
Dec 31, 2024 610.00
Sep 30, 2024 640.00
Jun 30, 2024 141.00
Mar 31, 2024 59.00
Dec 31, 2023 24.00
Sep 30, 2023 -529.00
Jun 30, 2023 847.00
Mar 31, 2023 185.00
Dec 31, 2022 -54.00
Sep 30, 2022 -359.00
Jun 30, 2022 -344.00
Mar 31, 2022 503.00
Dec 31, 2021 -95.00
Sep 30, 2021 173.00
Jun 30, 2021 874.00